Skip to main content
SpringerLink
Log in

Nanoparticles as Targeted Drug Delivery Agents: Synthesis, Mechanism and Applications

  • Chapter
  • First Online:
Recent Trends in Nanomaterials

Part of the book series: Advanced Structured Materials ((STRUCTMAT,volume 83))

Abstract

Extensive research is going on therapeutic delivery but the problem to develop a proper carrier still exists that can deliver drugs to specific sites of the body or target cells to treat diseases. The problems of therapeutic delivery are associated with low efficacy caused by carrier plasma instability and high toxicity, clearance by the reticulo endothelial system (RES), as well as the existence of various intracellular barriers. Today nanotechnology is a developing field and applications of nanoparticles in drug delivery succeed to overcome the above hurdles. Nanoparticles enhance the gathering of drug in the affected tissues based on the surface properties and enhanced permeability and retention (EPR) effect. Therefore, nanoparticles increase the uptake of the drugs by cells and minimize the adverse effect through both specific and enhanced interactions between the targeted cells and nanoparticles. The small size of nanoparticles is responsible for its high surface area which is responsible to readily interact with biomolecules at the surface as well as inside the cells. This helps the target specificity for therapeutics. The use of nanoparticles helps to reduce the toxicity of the therapeutic agent, the treatment efficacy is improved, and side effects are decreased. The nanoparticles can be used in a stealth mode in which therapeutic agents are loaded into nanoparticles which are not identified by the immune system and nanoparticles carry the drugs to selectively targets. Recent research in the field of drug delivery is mainly focused on use of nanoparticles as drug carriers for health challenging diseases such as cancer, HIV, and diabetes. The common treatment for these diseases is not so much effective and most of the time the cure is death. Nanoparticles have been identified to securely carry the drugs to infected cells that can be a useful tool to fight the diseases. In case of cancer, traditional chemotherapy might not be successful because anticancer drugs disperse to the whole body and destroy both the normal and affected cells. Nanoparticles can replace this treatment with a more promising one that could meet these challenges. Current chapter is mainly focused on the targeted drug delivery by using nanoparticles. The mechanism of action of targeted delivery is discussed in detail with the applications of different types of nanoparticles in targeted delivery. The chapter also put some light on the synthetic procedures of nanoparticles for use in targeted drug delivery. The present chapter will be of great importance to both students and researchers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631–651 (2002)

    Article  Google Scholar 

  2. E.M. Martín del Valle, M.A. Galán, R.G. Carbonell, Drug delivery technologies: the way forward in the new decade. Ind. Eng. Chem. Res. 48, 2475–2486 (2009)

    Article  Google Scholar 

  3. A. Bansal, Y. Zhang, Photocontrolled nanoparticle delivery systems for biomedical applications. Acc. Chem. Res. 47, 3052–3060 (2014)

    Article  Google Scholar 

  4. K. Ulbrich, K. Holá, V. Šubr, A. Bakandritsos, J. Tuček, R. Zbořil, Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem. Rev. 116, 5338–5431 (2016)

    Article  Google Scholar 

  5. V. Torchilin, Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131–135 (2011)

    Article  Google Scholar 

  6. H. Koo, S. Lee, J.H. Na, S.H. Kim, S.K. Hahn, K. Choi, I.C. Kwon, S.Y. Jeong, K. Kim, Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. Angew. Chem. Int. Ed. 51, 11836–11840 (2012)

    Article  Google Scholar 

  7. E. Gullotti, Y. Yeo, Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol. Pharm. 6, 1041–1051 (2009)

    Article  Google Scholar 

  8. W. Gao, J. Chan, O.C. Farokhzad, pH-responsive nanoparticles for drug delivery. Mol. Pharm. 7, 1913–1920 (2010)

    Article  Google Scholar 

  9. X. Guo, F.C. Szoka, Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 36, 335–341 (2003)

    Article  Google Scholar 

  10. J. Lewandowska-Łańcucka, K. Mystek, A. Gilarska, K. Kamiński, M. Romek, B. Sulikowski, M. Nowakowska, Silicone-stabilized liposomes as a possible novel nanostructural drug carrier. Colloids Surf. B Biointerfaces 143, 359–370 (2016)

    Article  Google Scholar 

  11. J.O. Eloy, M. Claro de Souza, R. Petrilli, J.P.A. Barcellos, R.J. Lee, J.M. Marchetti, Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf. B Biointerfaces. 123, 345–363 (2014)

    Article  Google Scholar 

  12. L. Sercombe, T. Veerati, F. Moheimani, S.Y. Wu, A.K. Sood, S. Hua, Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015)

    Article  Google Scholar 

  13. J. Hu, K. Hu, Y. Cheng, Tailoring the dendrimer core for efficient gene delivery. Acta Biomater. 35, 1–11 (2016)

    Article  Google Scholar 

  14. K. Madaan, S. Kumar, N. Poonia, V. Lather, D. Pandita, Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J. Pharm. Bioallied Sci. 6, 139–150 (2014)

    Article  Google Scholar 

  15. S.R. Mudshinge, A.B. Deore, S. Patil, C.M. Bhalgat, Nanoparticles: emerging carriers for drug delivery. Saudi Pharm. J. 19, 129–141 (2011)

    Article  Google Scholar 

  16. H.-Q. Wu, C.-C. Wang, Biodegradable smart nanogels: a new platform for targeting drug delivery and biomedical diagnostics. Langmuir 32, 6211–6225 (2016)

    Article  Google Scholar 

  17. Y. Shi, C.F. van Nostrum, W.E. Hennink, Interfacially hydrazone cross-linked thermosensitive polymeric micelles for acid-triggered release of paclitaxel. ACS Biomater. Sci. Eng. (2015) (150512181754006)

    Google Scholar 

  18. E.L. Cooper, TMU: brain injury. J. Exp. Clin. Med. 3, 1–2 (2011)

    Article  Google Scholar 

  19. S.D. Brown, P. Nativo, J.A. Smith, D. Stirling, P.R. Edwards, B. Venugopal, D.J. Flint, J.A. Plumb, D. Graham, N.J. Wheate, Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 132, 4678–4684 (2010)

    Article  Google Scholar 

  20. W. Cai, T. Gao, H. Hong, J. Sun, Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 1, 17–32 (2008)

    Article  Google Scholar 

  21. U. Pliquett, Electrochemotherapy—a new way for enhancing cancer treatment. Chemother. 01 (2012)

    Google Scholar 

  22. Y. Chen, NEK1 protein kinase as a target for anticancer therapeutics. Chemother. 01, e118 (2012)

    Google Scholar 

  23. C. Polenz, Adjuvant chemotherapy for colorectal cancer-timing is everything. Chemother. 02, 110 (2013)

    Google Scholar 

  24. A.K. Maiti, Emerging biology of circulating tumor cells (CTCs) in cancer detection and chemotherapy. Chemother. 02 (2013); R. Alam, D. Wahi, R. Singh, D. Sinha, V. Tandon, A. Grover, Rahisuddin, Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents. Bioorg. Chem. 69, 77 (2016)

    Google Scholar 

  25. M.L. Thomas, K.M. Coyle, M. Sultan, A. Vaghar-Kashani, P. Marcato, Chemoresistance in cancer stem cells and strategies to overcome resistance. Chemother. 03 (2014)

    Google Scholar 

  26. R.S. Huang, Cancer epigenetics: mechanisms and crosstalk of a HDAC inhibitor, vorinostat. Chemother. 02 (2013)

    Google Scholar 

  27. A.A. Bogdanov, M. Mazzanti, G. Castillo, E. Bolotin, Protected graft copolymer (pgc) in imaging and therapy: a platform for the delivery of covalently and non-covalently bound drugs. Theranostics 2, 553–576 (2012)

    Article  Google Scholar 

  28. R. Duncan, Drug-polymer conjugates: potential for improved chemotherapy. Anticancer Drugs 3, 175–210 (1992)

    Article  Google Scholar 

  29. J.R. McCarthy, J.M. Perez, C. Brückner, R. Weissleder, Polymeric nanoparticle preparation that eradicates tumors. Nano Lett. 5, 2552–2556 (2005)

    Article  Google Scholar 

  30. C.-M.J. Hu, L. Zhang, S. Aryal, C. Cheung, R.H. Fang, L. Zhang, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. U. S. A. 108, 10980–10985 (2011)

    Article  Google Scholar 

  31. A.K. Maiti, Emerging biology of circulating tumor cells (CTCs) in cancer detection and chemotherapy. Chemother. 02 (2013)

    Google Scholar 

  32. D.W. Kim, S.Y. Kim, H.K. Kim, S.W. Kim, S.W. Shin, J.S. Kim, K. Park, M.Y. Lee, D.S. Heo, Multicenter phase II trial of genexol-PM, a novel cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009–2014 (2007)

    Article  Google Scholar 

  33. R. Trivedi, U.B. Kompella, Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond). 5, 485–505 (2010)

    Article  Google Scholar 

  34. H. Xin, L. Chen, J. Gu, X. Ren, Z. Wei, J. Luo, Y. Chen, X. Jiang, X. Sha, X. Fang, Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int. J. Pharm. 402, 238–247 (2010)

    Article  Google Scholar 

  35. K.T. Al-Jamal, W.T. Al-Jamal, S. Akerman, J.E. Podesta, A. Yilmazer, J.A. Turton, A. Bianco, N. Vargesson, C. Kanthou, A.T. Florence, G.M. Tozer, K. Kostarelos, Systemic antiangiogenic activity of cationic poly-l-lysine dendrimer delays tumor growth. Proc. Natl. Acad. Sci. U. S. A. 107, 3966–3971 (2010)

    Article  Google Scholar 

  36. I.J. Majoros, A. Myc, T. Thomas, C.B. Mehta, J.R. Baker, PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 7, 572–579 (2006)

    Article  Google Scholar 

  37. R. Rupp, S.L. Rosenthal, L.R. Stanberry, VivaGel (SPL7013 Gel): a candidate dendrimer—microbicide for the prevention of HIV and HSV infection. Int. J. Nanomed. 2, 561–566 (2007)

    Google Scholar 

  38. S. Aryal, C.-M.J. Hu, L. Zhang, Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol. Pharm. 8, 1401–1407 (2011)

    Article  Google Scholar 

  39. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007)

    Article  Google Scholar 

  40. D. Zhu, W. Tao, H. Zhang, G. Liu, T. Wang, L. Zhang, X. Zeng, L. Mei, Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater. 30, 144–154 (2016)

    Article  Google Scholar 

  41. Z. Ji, G. Lin, Q. Lu, L. Meng, X. Shen, L. Dong, C. Fu, X. Zhang, Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J. Colloid Interface Sci. 365, 143–149 (2012)

    Article  Google Scholar 

  42. B. Ihova, Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data. J. Control. Release 91, 1–16 (2003)

    Article  Google Scholar 

  43. K. Kostarelos, L. Lacerda, G. Pastorin, W. Wu, S. Wieckowski, J. Luangsivilay, S. Godefroy, D. Pantarotto, J.-P. Briand, S. Muller, M. Prato, A. Bianco, Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2, 108–113 (2007)

    Article  Google Scholar 

  44. L. Lacerda, S. Raffa, M. Prato, A. Bianco, K. Kostarelos, Cell-penetrating CNTs for delivery of therapeutics. Nano Today 2, 38–43 (2007)

    Article  Google Scholar 

  45. H.-F. Liang, C.-T. Chen, S.-C. Chen, A.R. Kulkarni, Y.-L. Chiu, M.-C. Chen, H.-W. Sung, Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 27, 2051–2059 (2006)

    Article  Google Scholar 

  46. S. Jaspart, P. Bertholet, G. Piel, J.-M. Dogné, L. Delattre, B. Evrard, Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur. J. Pharm. Biopharm. 65, 47–56 (2007)

    Article  Google Scholar 

  47. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, Z. Zhang, Solid lipid nanoparticles for pulmonary delivery of insulin. Int. J. Pharm. 356, 333–344 (2008)

    Article  Google Scholar 

  48. J. Varshosaz, S. Ghaffari, S.F. Mirshojaei, A. Jafarian, F. Atyabi, F. Kobarfard, S. Azarmi, Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. Biomed Res. Int. 2013 (2013)

    Google Scholar 

  49. N. Nafee, A. Husari, C.K. Maurer, C. Lu, C. De Rossi, A. Steinbach, R.W. Hartmann, C.M. Lehr, M. Schneider, Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. J. Control. Release. 192, 131–140 (2014)

    Article  Google Scholar 

  50. G.A. Islan, P.C. Tornello, G.A. Abraham, N. Duran, G.R. Castro, Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization. Colloids Surf. B Biointerfaces. 143, 168–176 (2016)

    Google Scholar 

  51. C. Carbon, Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47, 9–14 (2001)

    Article  Google Scholar 

  52. C.-L. Fang, S.A. Al-Suwayeh, J.-Y. Fang, Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat. Nanotechnol. 7, 41–55 (2013)

    Article  Google Scholar 

Download references

Acknowledgements

Akrema greatly acknowledges the financial support from University Grants Commission in the form of BSR Fellowship. R. Arif also thanks to UGC for Major Research Project (F. No. 41-238/2012).

Author information

Authors and Affiliations

  1. Department of Chemistry, Jamia Millia Islamia, New Delhi, 110025, India

    Rahisuddin, Pattan Sirajuddin Nayab,  Akrema & Rizwan Arif

  2. Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025, India

    Mohammad Abid

  3. Eppley Institute for Research in Cancer & Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA

    Mohammad Abid

Authors
  1. Rahisuddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pattan Sirajuddin Nayab
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akrema
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rizwan Arif
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad Abid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rahisuddin .

Editor information

Editors and Affiliations

  1. Department of Applied Sciences and Humanities, Jamia Millia Islamia, New Delhi, Delhi, India

    Zishan Husain Khan

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Rahisuddin, Nayab, P.S., Akrema, Arif, R., Abid, M. (2017). Nanoparticles as Targeted Drug Delivery Agents: Synthesis, Mechanism and Applications. In: Khan, Z. (eds) Recent Trends in Nanomaterials. Advanced Structured Materials, vol 83. Springer, Singapore. https://doi.org/10.1007/978-981-10-3842-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation